Fabrizio De Ponti - Concepedia

Author

Fabrizio De Ponti

University of Bologna ORCID

Also Known As

De Ponti, Elisa Ballarini, F DE PONTI, F DEPONTI, F De Ponti, F Di Mario, F PONTI, F de Ponti, F. DE PONTI, F. De Ponti

403

Publications

11.2K

Citations

H-Index

178

Concepts

All Affiliations

University of Bologna University of Pavia IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola University of Verona Istituti di Ricovero e Cura a Carattere Scientifico

About

Fabrizio De Ponti is an author at University of Bologna specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	62	2.7K
2	Health Sciences	9	9	318
3	Public Health	9	9	276
4	Social Sciences	6	6	164
5	Engineering	1	1	24

Fabrizio De Ponti

133

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Toward a Pharmacophore for Drugs Inducing the Long QT Syndrome: Insights from a CoMFA Study of HERG K<sup>+</sup> Channel Blockers Andrea Cavalli, Elisabetta Poluzzi, Fabrizio De Ponti, Journal of Medicinal Chemistry Molecular PharmacologyChannelopathiesLong Qt SyndromeSignal TransductionHerg Blocking Potency	2002	383
Intestinal Serotonin Release, Sensory Neuron Activation, and Abdominal Pain in Irritable Bowel Syndrome Cesare Cremon, Giovanni Carini, Bingxian Wang, The American Journal of Gastroenterology	2011	218
Nerve Fiber Outgrowth Is Increased in the Intestinal Mucosa of Patients With Irritable Bowel Syndrome Giovanni Dothel, Maria Raffaella Barbaro, Hélène Boudin, Gastroenterology Functional Gastrointestinal DisorderMedicineGastroenterologyIntestinal MucosaGastrointestinal Pathology	2015	154
Drug‐induced <i>torsades de pointes</i>: data mining of the public version of the FDA Adverse Event Reporting System (AERS) Elisabetta Poluzzi, Emanuel Raschi, Ugo Moretti, Pharmacoepidemiology and Drug Safety	2009	139
Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility Roberto De Giorgio, Monica Bovara, Giovanni Barbara, Gastroenterology ApoptosisImmunologyParaneoplastic Gut DysmotilityCell DeathPathology	2003	133
Antimicrobials and the Risk of Torsades de Pointes Elisabetta Poluzzi, Emanuel Raschi, Domenico Motola, Drug Safety Antimicrobial SusceptibilityHealth SciencesAntibioticsMedicineAntimicrobial Chemotherapy	2010	121
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database Emanuel Raschi, Carlo Piccinni, Elisabetta Poluzzi, Acta Diabetologica Metabolic SyndromeDiabetes ManagementHealth PolicyInsulin ManagementDiabetes	2011	120
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment Emanuel Raschi, Michele Fusaroli, Andrea Ardizzoni, Breast Cancer Research and Treatment	2020	103
Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases Roberto De Giorgio, Giovanni Barbara, Vincenzo Stanghellini, The American Journal of Gastroenterology Morphofunctional FeaturesImmunologyGastroenterologyPathologyExperimental Pathology	2002	102
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System Emanuel Raschi, Alessandra Mazzarella, Ippazio Cosimo Antonazzo, Targeted Oncology Drug SafetyDisproportionality AnalysisImmunotoxicologyAdverse EventMedicine	2019	95

Page 1